Last $42.47 USD
Change Today -0.85 / -1.96%
Volume 241.1K
HRC On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

hill-rom holdings inc (HRC) Snapshot

Open
$43.15
Previous Close
$43.32
Day High
$43.15
Day Low
$42.44
52 Week High
01/22/14 - $44.64
52 Week Low
02/5/14 - $34.94
Market Cap
2.4B
Average Volume 10 Days
490.4K
EPS TTM
$1.52
Shares Outstanding
57.4M
EX-Date
09/12/14
P/E TM
27.9x
Dividend
$0.61
Dividend Yield
1.40%
Current Stock Chart for HILL-ROM HOLDINGS INC (HRC)

hill-rom holdings inc (HRC) Related Businessweek News

No Related Businessweek News Found

hill-rom holdings inc (HRC) Details

Hill-Rom Holdings, Inc. manufactures and provides medical technologies and related services for the health care industry worldwide. It operates in three segments; North America, Surgical and Respiratory Care, and International. The company offers patient care systems, safe mobility and handling solutions, medical equipment rental services, surgical products, and information technology solutions, as well as non-invasive therapeutic products for various acute and chronic medical conditions. It rents and sells patient care systems, which include various bed systems, and integrated and non-integrated therapeutic bed surfaces, as well as mobility solutions for use in high, mid, and low acuity settings. The company also rents and sells non-invasive therapeutic products and surfaces for the prevention and treatment of various acute and chronic medical conditions, including pulmonary, wound, and bariatric conditions; and provides rental and health care provider asset management services for moveable medical equipment, such as ventilators, defibrillators, intravenous pumps, and patient monitoring equipment. In addition, the company provides architectural products comprising head walls and power columns; and health care furniture solutions. Further, it develops and markets various communications technologies and software solutions to improve patient safety at the point of care; offers surgical products, including positioning devices for use in shoulder, hip, spinal, and lithotomic surgeries, as well as platform-neutral positioning accessories for operating room tables; and offers operating room disposable products, such as scalpel and blade and handle systems, disposable scalpels, skin markers, and other disposable products. The company sells its products primarily to acute and extended care health care facilities through direct sales force and distributors, as well as to patients in home. Hill-Rom Holdings, Inc. was founded in 1969 and is based in Batesville, Indiana.

7,000 Employees
Last Reported Date: 08/7/14
Founded in 1969

hill-rom holdings inc (HRC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $942.6K
Chief Financial Officer and Treasurer
Total Annual Compensation: $208.9K
Senior Vice President and President of Intern...
Total Annual Compensation: $399.4K
Chief Legal Officer, Senior Vice President of...
Total Annual Compensation: $443.7K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $335.5K
Compensation as of Fiscal Year 2013.

hill-rom holdings inc (HRC) Key Developments

Hill-Rom Holdings, Inc. Declares Fourth Quarter 2014 Dividend, Payable on September 30, 2014

Hill-Rom Holdings, Inc. announced that its Board of Directors have declared a fiscal year 2014 fourth quarter dividend of $0.1525 per share. The dividend is payable on September 30, 2014 to shareholders of record as of the close of business on September 16, 2014.

Hill-Rom Holdings, Inc. Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014; Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2014

Hill-Rom Holdings, Inc. reported consolidated earnings results for the third quarter and nine months ended June 30, 2014. For the quarter, the company's total revenues were $397.6 million compared to $424.2 million for the same period of last year. Operating profit was $38 million compared to $36.2 million for the same period of last year. Net income was $26.1 million or $0.45 per diluted share compared to $23.4 million or $0.39 per diluted share for the same period of last year. Adjusted income before taxes was $48.1 million compared to $49.6 million for the same period of last year. Adjusted diluted earnings per share were $0.59 compared to $0.57 for the same period of last year. Adjusted EBITDA was $68.3 million compared to $73.5 million a year ago. For the nine months, the company's total revenues were $1,206.3 million compared to $1,278.3 million for the same period of last year. Operating profit was $87.2 million compared to $106.8 million for the same period of last year. Net income was $36.0 million or $0.61 per diluted share compared to $69.7 million or $1.15 per diluted share for the same period of last year. Adjusted income before taxes was $128.4 million compared to $147.5 million for the same period of last year. Adjusted diluted earnings per share were $1.51 compared to $1.67 for the same period of last year. Adjusted EBITDA was $193.7 million compared to $223.0 million a year ago. Net cash provided by operating activities was $134.2 million compared to $167.7 million a year ago. Capital expenditures and purchase of intangibles were $44.4 million compared to $49.7 million for the same period of last year. For the fourth quarter of fiscal 2014, Hill-Rom expects revenue growth of 6% to 8%. This reflects: currency benefit of approximately 1% at current rates; and incremental revenue from the Trumpf Medical acquisition. The company's guidance for fourth quarter adjusted earnings per diluted share is $0.68 to $0.72, which excludes acquisition-related intangible amortization expense. For full year fiscal 2014, Hill-Rom expects revenue decline of approximately 2% to 3%. This reflects: currency benefit of approximately 1% at current rates; and incremental revenue from the Trumpf Medical acquisition. Adjusted earnings per diluted share is expected to be $2.20 to $2.24, which excludes acquisition-related intangible amortization expense, cash flow from operations to be approximately $240 million, excluding cash outflows related to restructuring actions, and adjusted EBITDA for the full year to be approximately $280 million. The company anticipates $65 million to $70 million of CapEx investment for the full year.

Hill-Rom Holdings, Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 02:50 PM

Hill-Rom Holdings, Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 02:50 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: John J. Greisch, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRC:US $42.47 USD -0.85

HRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $102.81 USD -0.25
Herman Miller Inc $29.89 USD -0.365
Invacare Corp $12.66 USD -0.35
Teleflex Inc $106.16 USD -1.36
West Pharmaceutical Services Inc $44.32 USD -0.18
View Industry Companies
 

Industry Analysis

HRC

Industry Average

Valuation HRC Industry Range
Price/Earnings 35.7x
Price/Sales 1.5x
Price/Book 3.0x
Price/Cash Flow 34.9x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HILL-ROM HOLDINGS INC, please visit www.hill-rom.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.